药物不良反应杂志
藥物不良反應雜誌
약물불량반응잡지
ADVERSE DRUG REACTIONS JOURNAL
2015年
2期
148-149
,共2页
羟基脲%溃疡
羥基脲%潰瘍
간기뇨%궤양
Hydroxyurea%Ulcer
例1男性,69岁,因慢性粒细胞白血病服用羟基脲1.0 g/d,1年后左足外踝部出现溃疡且迁延不愈达5年。检查见溃疡大小约8 cm ×6 cm,其上附着黄色坏死组织,周围皮肤水肿并出现红斑,触痛明显。给予哌拉西林舒巴坦钠3.0 g静脉滴注,1次/12 h,共10 d。第10、35天分别行清创+创面负压封闭+自体皮移植术,但第1次术后14 d和第2次术后10 d均出现皮片坏死,患者放弃治疗。例2男性,80岁,因慢性粒细胞白血病服用羟基脲1.0 g/d,1年后右足跟及左足外踝出现多处溃疡且迁延不愈达1年。检查见溃疡最大者约6 cm ×4 cm,其上附着黄白色坏死组织,无新鲜肉芽,周围皮肤水肿并出现红斑,触痛明显。给予哌拉西林舒巴坦钠3.0 g静脉滴注,1次/12 h,并给予银离子联合交互式敷料外敷,1次/d。24 h后患者创面疼痛减轻;5 d后创面出现新鲜肉芽,坏死组织脱落;15 d 创面出现上皮化;40 d创面基本愈合。2例患者治疗溃疡过程中均按原剂量服用羟基脲。
例1男性,69歲,因慢性粒細胞白血病服用羥基脲1.0 g/d,1年後左足外踝部齣現潰瘍且遷延不愈達5年。檢查見潰瘍大小約8 cm ×6 cm,其上附著黃色壞死組織,週圍皮膚水腫併齣現紅斑,觸痛明顯。給予哌拉西林舒巴坦鈉3.0 g靜脈滴註,1次/12 h,共10 d。第10、35天分彆行清創+創麵負壓封閉+自體皮移植術,但第1次術後14 d和第2次術後10 d均齣現皮片壞死,患者放棄治療。例2男性,80歲,因慢性粒細胞白血病服用羥基脲1.0 g/d,1年後右足跟及左足外踝齣現多處潰瘍且遷延不愈達1年。檢查見潰瘍最大者約6 cm ×4 cm,其上附著黃白色壞死組織,無新鮮肉芽,週圍皮膚水腫併齣現紅斑,觸痛明顯。給予哌拉西林舒巴坦鈉3.0 g靜脈滴註,1次/12 h,併給予銀離子聯閤交互式敷料外敷,1次/d。24 h後患者創麵疼痛減輕;5 d後創麵齣現新鮮肉芽,壞死組織脫落;15 d 創麵齣現上皮化;40 d創麵基本愈閤。2例患者治療潰瘍過程中均按原劑量服用羥基脲。
례1남성,69세,인만성립세포백혈병복용간기뇨1.0 g/d,1년후좌족외과부출현궤양차천연불유체5년。검사견궤양대소약8 cm ×6 cm,기상부착황색배사조직,주위피부수종병출현홍반,촉통명현。급여고랍서림서파탄납3.0 g정맥적주,1차/12 h,공10 d。제10、35천분별행청창+창면부압봉폐+자체피이식술,단제1차술후14 d화제2차술후10 d균출현피편배사,환자방기치료。례2남성,80세,인만성립세포백혈병복용간기뇨1.0 g/d,1년후우족근급좌족외과출현다처궤양차천연불유체1년。검사견궤양최대자약6 cm ×4 cm,기상부착황백색배사조직,무신선육아,주위피부수종병출현홍반,촉통명현。급여고랍서림서파탄납3.0 g정맥적주,1차/12 h,병급여은리자연합교호식부료외부,1차/d。24 h후환자창면동통감경;5 d후창면출현신선육아,배사조직탈락;15 d 창면출현상피화;40 d창면기본유합。2례환자치료궤양과정중균안원제량복용간기뇨。
Patient 1,a 69-year-old male with chronic myelocytic leukemia received hydroxycarbamide 1. 0 g/d. The refractory ulcer developed on his lateral malleolus in left foot one year later and lasted for 5 years. Physical examination showed the ulcerˊs area was 8 cm × 6 cm. The yellow necrotic tissue adhered to the surface of ulcers. The edema,erythema and severe tenderness appeared in surrounding skin of ulcers. He was given an IV infusion of piperacillin sodium and sulbactam sodium 3. 0 g twice daily for 10 days. The patient received an operation of debride +vacuum sealing +autologous skin graft on day 10 and 35 of hospitalization, respectively. But the necrosis in skin graft appeared on the fourteenth day after the first operation and the tenth days after the second operation,respectively. The patient gave up the treatment and were discharged. Patient 2,an 80-year-old male with chronic myelocytic leukemia received hydroxycarbamide 1. 0 g/d. The refractory ulcers developed on his right and left heels one year later and lasted for one year. Physical examination showed that the maximal ulcerˊs area was 6 cm × 4 cm. There were yellow necrotic tissue adhering to the surface of ulcers without granulation tissue. The edema,erythema and severe tenderness were found in the surrounding skin of ulcers. He was given an IV infusion of piperacillin sodium and sulbactam sodium 3. 0 g twice daily and a combined interactive Ag dressing( HARTMANN,Germany)on the surface of ulcers once daily. The patient felt the pain decreased 24 hours later. On day 5,new granulation tissue appeared on the surface of a wound, and the necrotic tissue fell off. On day 15,epithelialization appeared on the surface of the wound. On day 40, scar formation on the surface of the wound appeared and the patient was discharged. The two patients continued to take the hydroxycarbamide according to the original dose during the process of treatment of ulcer.